Document Detail


Dynamic contrast-enhanced magnetic resonance imaging and blood oxygenation level-dependent magnetic resonance imaging for the assessment of changes in tumor biology with treatment.
MedLine Citation:
PMID:  22043053     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Functional magnetic resonance imaging (MRI) techniques are rapidly gaining importance as methods of exploring the pathophysiological properties of breast carcinomas. In the neoadjuvant setting where the primary tumor remains in situ, functional MRI is able to noninvasively evaluate microenvironmental features such as blood flow and oxygenation. Dynamic contrast-enhanced MRI provides information on tumor vascularity with evidence suggesting a role in predicting response to neoadjuvant chemotherapy. The spatial heterogeneity of response to anti-angiogenic and vascular disrupting agents can also be depicted. There is preliminary data supporting blood oxygenation level-dependent MRI as a potential marker of tumor oxygenation, with the ability to characterize tissue oxygenation changes with neoadjuvant chemotherapy. Additionally, advanced MR sequences such as diffusion-weighted MRI and MR spectroscopy have the potential to provide information relating to cellularity and metabolism, respectively.
Authors:
Sonia P Li; Anwar R Padhani; Andreas Makris
Related Documents :
11788743 - Gerstmann syndrome in systemic lupus erythematosus: neuropsychological, neuroimaging an...
17622713 - Interleukin-1alpha and -1beta promoter polymorphisms in taiwanese patients with dementia.
19008123 - The association of meniscal damage with joint effusion in persons without radiographic ...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of the National Cancer Institute. Monographs     Volume:  2011     ISSN:  1745-6614     ISO Abbreviation:  J. Natl. Cancer Inst. Monographs     Publication Date:  2011  
Date Detail:
Created Date:  2011-11-01     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9011255     Medline TA:  J Natl Cancer Inst Monogr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  103-7     Citation Subset:  IM    
Affiliation:
Academic Oncology Unit, Mount Vernon Cancer Centre, Rickmansworth Rd, Northwood, Middlesex HA62RN, UK. amakris@nhs.net.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Predictive immunohistochemical biomarkers in the context of neoadjuvant therapy for breast cancer.
Next Document:  The triple-negative subtype: new ideas for the poorest prognosis breast cancer.